Total Payments
$21,707
2024 Payments
$2,762
Companies
72
Transactions
865
Medicare Patients
8,034
Medicare Billing
$819,501
Payment Breakdown by Category
Food & Beverage$15,577 (71.8%)
Consulting$4,000 (18.4%)
Travel$1,293 (6.0%)
Education$837.66 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,577 | 844 | 71.8% |
| Consulting Fee | $4,000 | 1 | 18.4% |
| Travel and Lodging | $1,293 | 4 | 6.0% |
| Education | $837.66 | 16 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $5,606 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,409 | 100 | $0 (2024) |
| PFIZER INC. | $971.49 | 71 | $0 (2024) |
| Janssen Biotech, Inc. | $901.29 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $886.92 | 56 | $0 (2024) |
| Eisai Inc. | $755.72 | 39 | $0 (2024) |
| Amgen Inc. | $722.13 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $701.47 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $669.13 | 37 | $0 (2024) |
| Lilly USA, LLC | $646.17 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,762 | 118 | Eisai Inc. ($250.44) |
| 2023 | $2,207 | 105 | Gilead Sciences, Inc. ($260.97) |
| 2022 | $2,009 | 66 | Janssen Biotech, Inc. ($237.75) |
| 2021 | $1,411 | 60 | AbbVie Inc. ($202.04) |
| 2020 | $1,052 | 55 | AstraZeneca Pharmaceuticals LP ($202.12) |
| 2019 | $2,396 | 144 | E.R. Squibb & Sons, L.L.C. ($339.90) |
| 2018 | $2,169 | 143 | E.R. Squibb & Sons, L.L.C. ($368.34) |
| 2017 | $7,703 | 174 | Bayer HealthCare Pharmaceuticals Inc. ($5,490) |
All Payment Transactions
865 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Oncology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Oncology | ||||||
| 11/20/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: NONE | ||||||
| 11/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $21.50 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/22/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: Oncology | ||||||
| 10/18/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: HEMATOLOGY | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $18.28 | General |
| 09/26/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.57 | General |
| Category: Hematology | ||||||
| 09/20/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: NONE | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.21 | General |
| 09/18/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 2,657 | 45,107 | $662,498 | $220,378 |
| 2022 | 29 | 1,482 | 35,429 | $525,172 | $173,930 |
| 2021 | 22 | 1,162 | 28,797 | $568,154 | $203,965 |
| 2020 | 38 | 2,733 | 22,452 | $897,372 | $221,229 |
Total Patients
8,034
Total Services
131,785
Medicare Billing
$819,501
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 328 | 604 | $170,487 | $53,548 | 31.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 100 | 387 | $77,697 | $34,583 | 44.5% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 23 | 36,750 | $110,250 | $31,609 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 111 | 156 | $44,048 | $19,789 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 152 | $22,355 | $8,755 | 39.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 53 | $20,670 | $6,946 | 33.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 75 | $18,750 | $6,841 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $20,142 | $5,878 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 242 | 502 | $18,072 | $5,136 | 28.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 253 | 575 | $11,500 | $4,771 | 41.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 19 | 215 | $12,900 | $4,461 | 34.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 251 | 578 | $19,074 | $4,347 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $11,634 | $4,199 | 36.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 187 | 286 | $15,730 | $3,773 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 61 | $8,540 | $3,645 | 42.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 27 | 72 | $10,800 | $3,330 | 30.8% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 16 | 151 | $6,795 | $2,653 | 39.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 11 | 11 | $5,894 | $1,822 | 30.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 54 | 72 | $7,344 | $1,801 | 24.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 96 | 115 | $6,900 | $1,688 | 24.5% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 52 | 68 | $5,644 | $1,677 | 29.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 91 | 109 | $6,322 | $1,559 | 24.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 52 | 70 | $4,200 | $1,474 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,908 | $1,188 | 30.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 41 | 57 | $3,705 | $1,014 | 27.4% |
About Dr. Albert Weeks, M.D
Dr. Albert Weeks, M.D is a Hematology & Oncology healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336147263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Weeks, M.D has received a total of $21,707 in payments from pharmaceutical and medical device companies, with $2,762 received in 2024. These payments were reported across 865 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($15,577).
As a Medicare-enrolled provider, Weeks has provided services to 8,034 Medicare beneficiaries, totaling 131,785 services with total Medicare billing of $819,501. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Germantown, TN
- Active Since 07/13/2005
- Last Updated 10/21/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1336147263
Products in Payments
- Nexavar (Drug) $5,503
- OPDIVO (Biological) $761.04
- Lenvima (Drug) $721.60
- KEYTRUDA (Biological) $566.98
- IMBRUVICA (Drug) $484.00
- ZEJULA (Drug) $464.94
- IBRANCE (Drug) $462.98
- XTANDI (Drug) $428.46
- KISQALI (Drug) $428.27
- ELIQUIS (Drug) $383.13
- Nerlynx (Drug) $325.21
- Venclexta (Drug) $304.27
- VENCLEXTA (Drug) $297.69
- CYRAMZA (Drug) $271.90
- REBLOZYL (Biological) $263.81
- Trodelvy (Drug) $260.17
- VERZENIO (Drug) $257.23
- XARELTO (Drug) $246.76
- NINLARO (Drug) $235.57
- SIR-Spheres Microspheres (Device) $228.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Germantown
Dr. Jason Porter, M.d, M.D
Hematology & Oncology — Payments: $695,369
Hematology & Oncology $695,369
Axel Grothey, M.d, M.D
Hematology & Oncology — Payments: $395,090
Hematology & Oncology $395,090
Bradley Somer, Md, MD
Hematology & Oncology — Payments: $117,191
Hematology & Oncology $117,191
Dr. Timothy Goggins, M.d, M.D
Hematology & Oncology — Payments: $91,094
Hematology & Oncology $91,094
Mr. Gang Tian, M.d, M.D
Hematology & Oncology — Payments: $67,957
Hematology & Oncology $67,957
Sylvia Richey, Md, MD
Hematology & Oncology — Payments: $26,784
Hematology & Oncology $26,784